About the Company
We do not have any company description for Avid Bioservices, Inc. at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $CDMO News
Avid Bioservices
Avid Bioservices, Inc. engages in the commercial manufacturing. The firm focuses on the biopharmaceutical products derived from mammalian cell culture for culture for biotechnology and ...
Laughing Water Capital - Avid Bioservices: A Few Years Away From Large, Relatively Sticky FCF
Avid is just a few years away from large, relatively sticky free cash flow, that should deserve a high multiple. Click here ...
OC Drugmakers Cut Headcounts, Close Offices
The Business Journal’s annual listing of the largest local players in the pharmaceutical industry shows a sector that remains ...
Avid Bioservices, Inc. 10.5 % Cum Conv Red Perp Pfd Registered Series E
ChatGPT won't save the planet. Nor will Copilot, or Stability AI, or Claude. But there is still a sustainable promise to machine learning.
Avid Bioservices Announces Receipt of Deficiency Notice from Nasdaq Regarding Late Form 10-Q
TUSTIN, Calif., March 20, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (Nasdaq:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO), announced today it receiv ...
Avid Bioservices Inc CDMO
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Avid Bioservices, Inc. (CDMO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
On March 6, 2024, Avid Bioservices filed a current report on Form 8-K with the SEC, which stated that the Company "received an acceleration notice (the "Acceleration Notice") from a holder of its ...
Avid Bioservices (CDMO) Tanks 30% After Disclosing Possible Accounting Restatements Due to $146 Million Acceleration Notice – Hagens Berman
Avid Bioservices, Inc. (CDMO) Investigation: “The investigation centers on Avid Bioservices’ failure to timely remove the restrictive legend on certain of its unregistered notes and the ...
Avid Bioservices, Inc. (CDMO)
Overall score is calculated based on proprietary scores based on sector averages in key company indicators: fair value, dividends, innovation, hiring, and insider sentiment. Note: if you don't see ...
Avid Bioservices, Inc. (CDMO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
On March 6, 2024, Avid Bioservices filed a current report on Form 8-K with the SEC, which stated that the Company "received an acceleration notice (the "Acceleration Notice") from a holder of its ...
Loading the latest forecasts...